PGIM Jennison Health Sciences Fund C (PHLCX)
10.06
-0.12
(-1.18%)
USD |
Oct 06 2026
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.97% | 1.400B | 0.61% | 81.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -243.60M | 14.07% |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund invests primarily in equity-related securities of U.S. firms engaged in the following industries: hospitals, nursing and residential care, health and medical insurance carriers, pharmaceutical and medicine companies, and medical equipment firms. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | PGIM |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
81
-691.44M
Peer Group Low
647.63M
Peer Group High
1 Year
% Rank:
88
-243.60M
-1.850B
Peer Group Low
2.180B
Peer Group High
3 Months
% Rank:
87
-329.09M
Peer Group Low
1.097B
Peer Group High
3 Years
% Rank:
84
-6.864B
Peer Group Low
969.40M
Peer Group High
6 Months
% Rank:
84
-1.113B
Peer Group Low
1.056B
Peer Group High
5 Years
% Rank:
83
-9.084B
Peer Group Low
971.41M
Peer Group High
YTD
% Rank:
87
-1.246B
Peer Group Low
974.03M
Peer Group High
10 Years
% Rank:
88
-12.63B
Peer Group Low
5.623B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of October 07, 2026.
Asset Allocation
As of August 31, 2026.
| Type | % Net |
|---|---|
| Cash | 0.00% |
| Stock | 92.83% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 7.17% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Eli Lilly & Co. | 16.84% | 1189.76 | 2.79% |
|
PGIM Core Government Money Market Fund
|
7.14% | -- | -- |
| Merck & Co., Inc. | 6.99% | 143.01 | 0.75% |
| UnitedHealth Group, Inc. | 5.57% | 380.77 | 1.18% |
| Thermo Fisher Scientific, Inc. | 4.82% | 664.82 | 1.25% |
| Vertex Pharmaceuticals, Inc. | 4.14% | 508.30 | 1.19% |
| argenx SE | 3.50% | 934.80 | 0.46% |
| Danaher Corp. | 3.33% | 218.57 | 1.37% |
| CVS Health Corp. | 2.77% | 89.10 | 3.08% |
| Insmed, Inc. | 2.41% | 102.86 | -2.25% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 1.00% |
| Actual Management Fee | 0.73% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | 1.00% |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1000.00 None |
| Minimum Subsequent Investment | 100.00 None |
TTM Distributions
| Type | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qualified Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Normal
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Qualified
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
LT Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Ordinary Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Non-Qual
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ST Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Interest
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Tax-Exempt
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ROC
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Other
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Total
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
As of September 30, 2026.
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund invests primarily in equity-related securities of U.S. firms engaged in the following industries: hospitals, nursing and residential care, health and medical insurance carriers, pharmaceutical and medicine companies, and medical equipment firms. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | PGIM |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (10-6-26) | 0.24% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 56 |
| Stock | |
| Weighted Average PE Ratio | 39.21 |
| Weighted Average Price to Sales Ratio | 14.19 |
| Weighted Average Price to Book Ratio | 10.50 |
| Weighted Median ROE | -3.38% |
| Weighted Median ROA | -3.86% |
| Return on Investment (TTM) | -1.35% |
| Earning Yield | 0.0278 |
| LT Debt / Shareholders Equity | 0.8137 |
| Number of Equity Holdings | 53 |
As of August 31, 2026
Growth Metrics
| EPS Growth (1Y) | 22.51% |
| EPS Growth (3Y) | 14.33% |
| EPS Growth (5Y) | 13.67% |
| Sales Growth (1Y) | 19.87% |
| Sales Growth (3Y) | 18.64% |
| Sales Growth (5Y) | 17.91% |
| Sales per Share Growth (1Y) | 20.58% |
| Sales per Share Growth (3Y) | 19.25% |
| Operating Cash Flow - Growth Rate (3Y) | 6.84% |
As of August 31, 2026
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:PHLCX", "name") |
| Broad Asset Class: =YCI("M:PHLCX", "broad_asset_class") |
| Broad Category: =YCI("M:PHLCX", "broad_category_group") |
| Prospectus Objective: =YCI("M:PHLCX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |